Back
Netcompany Group A/S Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Sell
50
NTCYF
Netcompany Group A/S
Last Price:
$48.41
Seasonality Move:
-0.93%
Sell
50
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$25.89
Seasonality Move:
2.09%
Sell
50
Netcompany Group A/S (NTCYF)
is a Sell
Is Netcompany Group A/S a Buy, Sell or Hold?
-
The current Netcompany Group A/S [NTCYF] share price is $48.41. The Score for NTCYF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
NTCYF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $25.90. The Score for AMPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTCYF Stock Price Chart
What is Netcompany Group A/S's stock price today?
-
The Netcompany Group A/S share price today is $48.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTCYF is experiencing slight buying pressure.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $25.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTCYF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 66 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.03 - 49.71) | Sell |
| Bollinger Bands (100): | (40.34 - 47.12) | Buy |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 47.31 | Sell |
| Chaikin Money Flow: | 236440 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.35 - 27.35) | Sell |
| Bollinger Bands (100): | (23.64 - 28.86) | Sell |
NTCYF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.41 | Sell |
| 20-day SMA: | 48.64 | Sell |
| 50-day SMA: | 44.93 | Buy |
| 200-day SMA: | 43.24 | Buy |
| 8-day EMA: | 48.41 | Sell |
| 20-day EMA: | 48.03 | Buy |
| 50-day EMA: | 46.14 | Buy |
| 200-day EMA: | 43.63 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.43 | Sell |
| 20-day SMA: | 26.47 | Sell |
| 50-day SMA: | 25.54 | Buy |
| 200-day SMA: | 25.72 | Buy |
| 8-day EMA: | 26.25 | Sell |
| 20-day EMA: | 26.31 | Sell |
| 50-day EMA: | 26.1 | Sell |
| 200-day EMA: | 28 | Sell |
Netcompany Group A/S Earnings Growth & NTCYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and an increase next year of $0.29 per share.
Netcompany Group A/S Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||